SELL BSE Ltd. — Bernstein
byBernsteinHorizon: NA (inferred 1 year)5 Nov 2026via ET Now (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this SELL call — facts from public sources, machine-classified. Not investment advice.
BSE Q2 Results: Profit Dips Sequentially. A 24% Fall In Derivatives Premium Turnover To Be Blamed?
NewsNdtv-Profit·4 Nov · 2d ago
1 other SEBI-registered advisor has an active long-term SELL call on this stock
Advisor consensus · same horizon·7 Oct · 1mo ago
BSE Q2 Review: Jefferies Maintains 'Underperform' Call, Raises Target Price
NewsNdtv-Profit·5 Nov · 2d ago
BSE Share Price: What is the fair value that divided analysts see for the stock after Q2 results
NewsCnbc-Tv18·5 Nov · 2d ago
Q2 Results Today Highlights: BSE, Apollo Hospitals, Sundaram Finance post higher profit in Q2; Biocon, Zydus Life profit declines
NewsHbl·4 Nov · 3d ago
BSE begins hunt for MD & CEO successor ahead of 2027 exit
NewsEt-Markets·24 Oct · 2w ago
BSE, Asia's Oldest Stock Exchange, Invites Applications For New MD And CEO Post
NewsNdtv-Profit·23 Oct · 2w ago
Long-term trend bullish — 200-day average rising over the past quarter
Technicals · trend·6 Nov · yesterday
4 advisors have active short-term BUY calls on this stock, with 2 issued in the last 14 days
Advisor consensus · adjacent horizon·6 Nov · yesterday
11 other SEBI-registered advisors have active long-term BUY calls on this stock, with 5 issued in the last 14 days
Advisor consensus · same horizon·6 Nov · yesterday
BSE Q2 net profit rises 45% to ₹809 crore, revenue up 34%
NewsHbl·4 Nov · 2d ago
BSE Ltd. reported consolidated financial results for the quarter and six months ended September 30, 2026, showing a net profit of 80,752 lakhs for the quarter.
NSE · Outcome of Board Meeting·4 Nov · 2d ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on BSE
- BUY — Shivangi Sarda, Motilal Oswal6 Nov 2026 · ~2 weeks · target ₹3,920 · Active
- BUY — Kunal Saraogi6 Nov 2026 · ~1 year · target ₹3,950 · Active
- BUY — Chandan Taparia, Motilal Oswal6 Nov 2026 · ~3 months · target ₹4,000 · Active
- BUY — Nilesh Jain, Centrum Broking5 Nov 2026 · ~2 weeks · target ₹3,900 · Active
- BUY — Motilal Oswal5 Nov 2026 · ~1 year · target ₹4,200 · Active
More from Bernstein
- BUY Titan Company6 Nov 2026 · ~1 year · target ₹5,400 · Active
- BUY Pfizer5 Nov 2026 · ~1 year · target ₹4,424 · Active
- BUY GlaxoSmithKline Pharmaceuticals5 Nov 2026 · ~1 year · target ₹3,430 · Active
- BUY Devyani International3 Nov 2026 · ~1 year · target ₹160 · Active
- BUY Laurus Labs30 Oct 2026 · ~1 year · target ₹3,500 · Active

